BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 399521)

  • 1. Preliminary transplant results obtained in a clinical trial of whole rabbit anti-human lymphocyte serum.
    Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonell R; Turner B
    Proc Clin Dial Transplant Forum; 1979; 9():95-8. PubMed ID: 399521
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose versus low-dose steroid therapy in conjunction with rabbit anti-human lymphocyte serum: flow cytometric monitoring of lymphocyte parameters.
    Green WF; Niblack GD; Richie RE; Johnson HK; MacDonell RC; Tallent MB
    Transplant Proc; 1984 Dec; 16(6):1517-9. PubMed ID: 6390857
    [No Abstract]   [Full Text] [Related]  

  • 3. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 4. T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation.
    Thistlethwaite JR; Buckingham M; Stuart JK; Gaber AO; Mayes JT; Stuart FP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):722-4. PubMed ID: 3079164
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
    Ono Y; Ohshima S; Fujita T; Kinukawa T; Matsuura O; Hirabayashi S; Takeuchi N
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between immune cell profile and rejection phase during a long-term follow-up study of Tunisian kidney and cardiac transplant patients.
    Mnasria K; Manaa J; Ghazouani E; Gritli N; Oueslati R
    Transplant Proc; 2004 Dec; 36(10):3175-9. PubMed ID: 15686723
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression and stimulation of T cell clones of renal transplant recipients by autologous post-transplant sera: a role for regulatory antibodies.
    Daniel V; Opelz G
    Transplant Proc; 1987 Oct; 19(5):4210-3. PubMed ID: 2960049
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved results of secondary cadaver retransplantation.
    Thomas F; Mendez-Picon G; Mohanakumar T; Thomas J; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():212-8. PubMed ID: 386314
    [No Abstract]   [Full Text] [Related]  

  • 9. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical use and results of immunodepressive treatment with anti-lymphocyte immunoglobulins in human renal allotransplantation].
    Scotti-Foglieni C; Salvadeo A; Cortinovis R; Colombo P; Donati GS; Uggeri F; Magni M; Pedroni G; del Bulletti G Robustelli
    Minerva Med; 1971 Sep; 62(70):3325-44. PubMed ID: 4939288
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of rabbit anti-human thymocyte globulin in cadaver kidney transplantation. Preliminary experiences.
    Groth CG; Lundgren G; Ringdén O; Berg B; Grimfors G; Bieber CP
    Scand J Urol Nephrol Suppl; 1981; 64():200-4. PubMed ID: 6755681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial with AHLG Behring: lack of effect on cadaveric renal graft survival.
    Jakobsen A; Flatmark A; Lundgren G; Solheim B; Groth CG
    Scand J Urol Nephrol Suppl; 1981; 64():205-12. PubMed ID: 6755682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies and early human transplant rejection.
    De Planque BA; Williams GM; Borst-Eilers E; Hume D
    Transplant Proc; 1971 Mar; 3(1):376-9. PubMed ID: 4106325
    [No Abstract]   [Full Text] [Related]  

  • 14. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
    Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C
    Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cadaver kidney homologous transplant. Clinical results in 64 patients].
    Moccetti T; Scheitlin W; Zaruba K; Largiadèr F; Linder E; Wegmann W
    Minerva Med; 1971 Nov; 62(89):4389-98. PubMed ID: 4146355
    [No Abstract]   [Full Text] [Related]  

  • 16. Pretransplant factors and transplant proteinuria in the prognosis of human kidney transplantation. A clinical study of 150 consecutive kidney graft recipients.
    Olander R
    Scand J Urol Nephrol; 1972; 16():Suppl 16:1-44. PubMed ID: 4631935
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal transplantation.
    Atkins RC
    Med J Aust; 1976 Feb; 1(8):230-3. PubMed ID: 772382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadaver-donor renal transplantation. Treatment of end-stage renal failure by dialysis.
    Sheil AG; Stewart JH; Johnson JR; May J; Sharp AM; Bashir H
    Minn Med; 1971 Jun; 54(6):463-7. PubMed ID: 4934441
    [No Abstract]   [Full Text] [Related]  

  • 19. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.